Arcutis Biotherapeutics Ownership | Who Owns Arcutis Biotherapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Arcutis Biotherapeutics Ownership Summary


Arcutis Biotherapeutics is owned by 103.37% institutional investors, 2.15% insiders. Jennison associates is the largest institutional shareholder, holding 9.93% of ARQT shares. Polar Capital Biotech S Inc is the top mutual fund, with 5.55% of its assets in Arcutis Biotherapeutics shares.

ARQT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockArcutis Biotherapeutics103.37%2.15%-5.52%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Jennison associates12.34M9.93%$171.89M
Suvretta capital management10.00M8.10%$93.04M
Rubric capital management lp9.82M7.95%$91.30M
Blackrock8.62M7.76%$80.19M
Blackrock funding, inc. /de9.15M7.36%$127.44M
Frazier life sciences management8.79M7.11%$81.70M
Polar capital6.88M5.57%$63.98M
Vanguard group6.44M5.18%$89.72M
State street5.13M4.62%$47.75M
Morgan stanley3.97M3.22%$36.95M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Pivotal bioventure partners investment advisor2.12M19.95%$29.54M
Tejara capital886.84K8.09%$12.35M
Frazier life sciences management8.79M3.82%$81.70M
Suvretta capital management10.00M3.42%$93.04M
Rubric capital management lp9.82M2.39%$91.30M
Cormorant asset management, lp2.52M1.36%$23.48M
Two seas capital lp762.19K1.15%$7.09M
Privium fund management b.v.325.71K1.03%$4.54M
Myda advisors200.00K0.70%$2.79M
Fishman jay a ltd/mi536.40K0.70%$7.47M

Top Buyers

HolderShares% AssetsChange
Rubric capital management lp9.82M2.39%2.31M
Suvretta capital management10.00M3.42%2.13M
Blackrock8.62M0.00%1.96M
Cercano management1.26M0.44%1.26M
Eversept partners, lp837.85K0.53%837.85K

Top Sellers

HolderShares% AssetsChange
State street5.13M0.00%-3.65M
Farallon capital management26.00K0.00%-1.75M
Braidwell lp---1.30M
Bain capital life sciences investors---1.03M
Franklin resources3.31M0.01%-941.10K

New Positions

HolderShares% AssetsChangeValue
Cercano management1.26M0.44%1.26M$17.49M
Eversept partners, lp837.85K0.53%837.85K$7.79M
Simplify asset management742.30K0.51%742.30K$10.34M
Norges bank532.79K0.00%532.79K$7.42M
Lazard asset management360.00K0.00%360.00K$3.35M

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-22.00
Byrne asset management-100.00
Colonial trust advisors-100.00
Bessemer group-110.00
Park place capital-183.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20241941.57%128,485,4751.57%1030.98%104-3.70%51-7.27%
Jun 30, 202419113.02%126,499,0251.37%1020.81%108-0.92%5544.74%
Mar 31, 202416924.26%124,792,42623.24%1120.94%10921.11%3846.15%
Dec 31, 2023136-4.23%101,262,58151.01%1090.93%9025.00%26-27.78%
Sep 30, 2023142-3.40%67,057,731-6.97%1080.79%72-24.21%3633.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Polar Capital Biotech S Inc6.50M5.55%-
Vanguard Total Stock Mkt Idx Inv3.27M2.79%42.00K
Jennison SMid Cap Core Equity3.09M2.64%-
PGIM Jennison Small Company A3.09M2.64%-
iShares Russell 2000 ETF2.93M2.50%-22.25K
Jennison Health Sciences Equity2.74M2.34%-
PGIM Jennison Health Sciences Z2.74M2.34%-
SPDR® S&P Biotech ETF2.27M1.94%-22.05K
Franklin Biotechnology Discv A(acc)USD2.05M1.75%-603.60K
Vanguard Institutional Extnd Mkt Idx Tr1.58M1.35%-31.06K

Recent Insider Transactions


DateNameRoleActivityValue
Feb 03, 2025Matsuda Masaru See RemarksSell$105.89K
Feb 03, 2025Watanabe Todd Franklin See RemarksSell$245.12K
Feb 03, 2025Welgus Howard G.-Sell$127.10K
Feb 03, 2025Burnett Patrick See RemarksSell$153.87K
Feb 03, 2025Edwards Larry Todd See RemarksSell$27.60K

Insider Transactions Trends


DateBuySell
2025 Q1-6
2024 Q4314
2024 Q3-9
2024 Q2-10
2024 Q116

ARQT Ownership FAQ


Who Owns Arcutis Biotherapeutics?

Arcutis Biotherapeutics shareholders are primarily institutional investors at 103.37%, followed by 2.15% insiders and -5.52% retail investors. The average institutional ownership in Arcutis Biotherapeutics's industry, Biotech Stocks , is 109.70%, which Arcutis Biotherapeutics falls below.

Who owns the most shares of Arcutis Biotherapeutics?

Arcutis Biotherapeutics’s largest shareholders are Jennison associates (12.34M shares, 9.93%), Suvretta capital management (10M shares, 8.10%), and Rubric capital management lp (9.82M shares, 7.95%). Together, they hold 25.98% of Arcutis Biotherapeutics’s total shares outstanding.

Does Blackrock own Arcutis Biotherapeutics?

Yes, BlackRock owns 7.76% of Arcutis Biotherapeutics, totaling 8.62M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 80.19M$. In the last quarter, BlackRock increased its holdings by 1.96M shares, a 29.49% change.

Who is Arcutis Biotherapeutics’s biggest shareholder by percentage of total assets invested?

Pivotal bioventure partners investment advisor is Arcutis Biotherapeutics’s biggest shareholder by percentage of total assets invested, with 19.95% of its assets in 2.12M Arcutis Biotherapeutics shares, valued at 29.54M$.

Who is the top mutual fund holder of Arcutis Biotherapeutics shares?

Polar Capital Biotech S Inc is the top mutual fund holder of Arcutis Biotherapeutics shares, with 5.55% of its total shares outstanding invested in 6.5M Arcutis Biotherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools